|

JUNE 9, 2015

Latham and Davis Polk work on Nevro's increased public offering

Latham & Watkins represented Menlo park-based Nevro Corp. in its upsized $240 million public offering of common stock. The offering of 4,705,880 shares is comprised of 1,764,705 shares being sold by the company and 2,941,175 shares being sold by existing shareholders. The medical device company develops products meant to treat chronic pain in individuals.

The Latham team was led by Menlo Park-based partner Anthony Richmond and Brian Cuneo.